Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS2)
Clinical trial NCT06958211 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06958211
- Sponsor
- Incyte Corporation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-12
- Primary completion
- 2026-10-09
- Enrollment
- 573
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.